Physician

James Hardy Gordon, M.D.

According to 2025 Medicare claims, James Gordon, M.D. (NPI: 1528149820) practices interventional pain management (ipm) in the Monroe, LA market, with the plurality of this provider's patient population coming from Ouachita, LA. This provider's primary affiliated billing organization is LOUISIANA PAIN CARE, LLC (NPI: 1659300739; TIN: 72-1476126) and primary practice location at 71201-8548.

Gordon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,102 traditional Medicare patients, billed 8,064 HCPCS/CPT codes, and received $540,843 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 14,264 prescription claims across 1,961 beneficiaries totaling $368,583 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2018 DME data shows 14 claims. Open Payments data shows 31 records totaling $1,500. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $530,672 to $368,583. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,693	15,650	$616,074
2016	1,573	10,733	$577,350
2017	1,857	12,226	$827,554
2018	1,926	11,889	$781,116
2019	1,881	12,630	$761,929
2020	1,359	9,756	$620,421
2021	1,493	10,199	$735,613
2022	1,487	9,656	$619,262
2023	1,098	8,415	$587,706
2024	1,102	8,064	$540,843

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,556	10,144	$530,672
2016	1,482	11,237	$510,368
2017	1,852	14,057	$548,178
2018	1,889	14,544	$591,916
2019	1,891	14,419	$495,244
2020	1,570	14,084	$397,821
2021	1,837	15,203	$436,276
2022	2,091	15,887	$451,559
2023	1,726	13,841	$361,407
2024	1,961	14,264	$368,583

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	11	$8,499
2016	23	23	$17,742
2017	84	84	$45,239
2018	14	14	$10,954
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	177	177	$118
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	250	270	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	814	2,197	$84
80307	Testing for presence of drug, by chemistry analyzers	478	852	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	616	1,251	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	5,278	154,365	$123,142
Oxycontin	Oxycodone Hcl	53	1,575	$48,433
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	1,504	43,833	$41,846
Gabapentin	Gabapentin	1,737	55,135	$17,267
Fentanyl	Fentanyl	168	4,993	$15,442

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$1,500	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Hardy Gordon, M.D.?

Tedicare shows public-source Medicare data for James Hardy Gordon, M.D. (NPI 1528149820), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Hardy Gordon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Hardy Gordon, M.D.?

James Hardy Gordon, M.D. is linked to LOUISIANA PAIN CARE, LLC (billing NPI 1659300739) in the available physician profile data.

Does James Hardy Gordon, M.D. have Open Payments data?

James Hardy Gordon, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.